Figure 2 | Scientific Reports

Figure 2

From: Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials

Figure 2

Comparisons between normal BMI Asian studies and overweight/obese BMI Asian studies in (A) HbA1c change, (B) fasting plasma glucose change, (C) 2-hour postprandial glucose change, (D) relative risk of HbA1c < 7.0% target achievement and (E) relative risk of HbA1c < 6.5% target achievement. BMI, body mass index; GLP-1RA, glucagon-like peptide-1 receptor agonist; SMD, standardized mean difference; CI, confidence interval; FPG, fasting plasma glucose; 2hPG, 2-hour postprandial glucose; RR, relative risk.

Back to article page